Chronic antioxidant treatment improves sympathetic functions and β-adrenergic pathway in the spontaneously hypertensive rats

Journal of Hypertension

Volumn 21, Issue 1, 2003, Pages 179-188

  Girouard, Hélène ^a   Chulak, Chantak ^a   LeJossec, Mireille ^a   Lamontagne, Daniel ^a   De Champlain, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood pressure; Catecholamines; Heart rate; Hypertension; adrenoceptors

Indexed keywords

ACETYLCYSTEINE; ADENYLATE CYCLASE; ANTIOXIDANT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; FLUORIDE SODIUM; FORSKOLIN; GUANYLYLIMIDODIPHOSPHATE; ISOPRENALINE; MELATONIN; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHRONOTROPISM; CONTROLLED STUDY; ENZYME ACTIVITY; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC FUNCTION; VASODILATATION;

EID: 0037251360     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200301000-00028     Document Type: Article

References (33)

1. Laycock SK, McMurray J, Kane KA, Parratt JR. Effects of chronic norepinephrine administration on cardiac function in rats, J Cardiovasc Pharmacol 1995; 26:584-589.
2. Liang C, Rounds NK, Dong E, Stevens SY, Shite J, Qin F. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial β-adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins. Circulation 2000; 102:96-103.
3. Ganguly PK. Impaired inotropic responses to adrenergic stimulation following aortic constriction: role of oxidation product of catecholamines. Angiology 1991; 42:133-139.
4. Lonnrot K, Porsti I, Alho H, Wu X, Hervonen A, Tolvanen JP, Control of arterial tone after long-term coenzyme Q10 supplementation in senescent rats. Br J Pharmacol 1998; 124:1500-1506.
5. Persad S, Takeda S, Dhalla NS. Alternations in beta-adrenoceptor mechanisms in hearts perfused with xanthine plus xanthine oxidase, J Cardiovasc Pharmacol Ther 1997; 2:115-124.
6. 2 in changing beta-adrenoceptor and adenylyl cyclase in ischemia-reperfused hearts. Mol Cell Biochem 1998; 186:99-106.
7. Masuda H, Kaneko M, Hong RB, Ikegaya T, Hayashi A, Kobayashi A, Yamazaki N. Effects of hydrogen peroxide on stimulatory guanine nucleotide-binding protein in rat heart. Jpn Circ J 1993; 57:1007-1015.
8. Tan CM, Xenoyannis S, Feldman RD. Oxidant stress enhances adenylyl cyclase activation. Circ Res 1995; 77:710-717.
9. Girouard H, Chulak C, LeJossec M, Lamontagne D, de Champlain J. Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats. J Hypertens 2001; 19:1369-1377.
10. Musso NR, Vergassola C, Pende A, Lotti G. Simultaneous measurement of plasma catecholamines (norepinephrine, epinephrine, dopamine) and free and methyldopamine (epinine) levels by HPLC with electrochemical detection. J Liquid Chromatogr 1990; 13:2217-2228.
11. K-Laflamme A, Oster L, Cardinal R, de Champlain J. Effects of renin-angiotensin blockade on sympathetic reactivity and β-adrenergic pathway in the spontaneously hypertensive rat. Hypertension 1997; 30:278-287.
12. Maack C, Tyroller S, Schnabel P, Cremers B, Dabew E, Südkamp N, Böhm M. Characterization of β1-selectivity, adrenoceptor-Gs-protein interaction and inverse agonism of nebivolol in human myocardium. Br J Pharmacol 2001; 132:1917-1826.
13. Salomon Y. Adenylate cyclase assay. Adv Cyclic Nucleotide Res 1979; 10:35-55.
14. 3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats, Am J Hypertens 1996; 9:61-69.
15. De Léan A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol Endocrinol Metab 1978; 235:E97-E102.
16. Ito H, Torii M, Suzuki T. Comparative study on free radical injury in the endothelium of SHR and WKY aorta. Clin Exp Pharrnacof Physiol 1995; 22 (suppl 1):157-159.
17. Suzuki H, Swei A, Zweifach BW, Schimd-Schonbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension 1995; 25: 1083-1089.
18. Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats, J Hypertens 2001; 19:741-748.
19. Cabassi A, Bouchard JF, Dumont EC, Girouard H, LeJossec M, Lamontagne D, et al. Effect of antioxidant treatments on nitrate tolerance development in normotensive and hypertensive rats. J Hypertens 2000; 18:187-196,
20. Cabassi A, Dumont EC, Girouard H, Bouchard JF, LeJossec M, Lamontagne D, et al. Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats.J Hypertens 2001; 19:1233-1244,
21. Nishiyama K, Yasue H, Moriyama Y, Tsunoda R, Ogawa H, Yoshimura M, Kugiyama K. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J 2001; 141: E9.
22. Cagnacci A, Arangino S, Angiolucci M, Maschio E, Longu G, Melis GB. Potentially beneficial cardiovascular effects of melatonin administration in women. J Pineal Res 1997; 22:16-19.
23. 1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 1998; 11:219-229.
24. Chahine R, Chert X, Yamaguchi N, de Champlain J, Nadeau R. Myocardial dysfunction and norepinephrine release in the isolated rat heart injured by electrolysis-induced oxygen free radicals. J Mol Cell Cardiol 1991; 23:279-286.
25. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release from rat hippocampal slices as a consequence of free radical formation. J Neurochem 1988; 51:1960-1962.
26. Opere C, Tang L, Imler M, Kim J, Okoye M Jr, Ohia S. Regulation of uveal sympathetic neurotransmission by peroxides. Invest Ophthalmol Vis Sci 1997; 38:842-847.
27. Wang M, Yokotani K, Nakamura K, Murakami Y, Okada S, Osumi Y. Melatonin inhibits the central sympatho-adrenomedullary outflow in rats. Jpn J Pharmacol 1999; 81:29-33.
28. Bucher B, Heitz C, Stoclet JC. Age-related changes of in vivo adrenergic responsiveness in normotensive and spontaneously hypertensive rats. Eur J Pharmacol 1984; 102:31-37.
29. Blankesteijn WM, Raat NJ, Willems PH, Thien T. Beta-adrenergic relaxation in mesenteric resistance arteries of spontaneously hypertensive and Wistar-Kyoto rats: the role of precontraction and intracellular Ca2+. J Cardiovasc Pharmacol 1996; 27:27-32.
30. Tejero-Taldo MI, Caffrey JL, Sun J, Mallet RT. Antioxidant properties of pyruvate mediate its potentiation of β-adrenergic inotropism in stunned myocardium, J Mol Cell Cardiol 1999; 31:1863-1872,
31. 1Badrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 1994; 91:10109-10113.
32. 2-adrenergic receptor. Am J Physiol Heart Circ Physiol 1996; 271:H630-H636.
33. Cui Y, Shen YT, Kalthof B, Iwase M, Sato N, Uechi M, et al. Identification and functional role of beta-adrenergic receptor subtypes in primate and rodent: in vivo versus isolated myocytes. J Mol Cell Cardiol 1996; 28:1307-1317.